Inactive
trl Triall
$ 0.002782
-0.01%
0.072851 BTC
-0.16%
2 satoshies
Market Cap
117,889.8177 $
24 Hour Trading Vol
48.4021 $
Circulating Supply
42,36 MLN.
Total Supply
172,11 MLN.
Max Supply
-
Fully Diluted Valuation
478,950 $
Coin Information
This coin is no longer being updated and is inactive. Its information may be updated in the future, but it is not currently active.
Last updated 27 February, 2025
Info
Contract
0xe2eb47954e821dc94e19013677004cd59be0
b17f
0x58f9102bf53cf186682bd9a281d3cd3c616e ec41
Website
Explorers
Community
Search on
API id
tags
Asset
|
1h
|
24h
|
7d
|
1m
|
1y
|
max
|
|---|---|---|---|---|---|---|
trl
| - | - | - | - | - | - |
Triall Price Statistics
0.002782 $
0.002782 $ / 0.002782 $
48.4021 $
#20631
117,889.8177 $
0.9755 $
-99.71%
04 November, 2021, (4 years ago)
0.001667 $
66.91%
08 September, 2024, (a year ago)
About Coin
Triall brings web 3.0 technology to clinical trials—medical research studies that test whether new medicines are safe and effective for humans. Clinical trial processes are notoriously costly and inefficient. They take many years, and involve increasing amounts of systems and data. The result is a lack of oversight, and uncertainty the integrity and authenticity of collected research data. It all drives the costs and reduces safety and reliability in the development of new medicines.
Since early 2018, Triall has been working with clinical trial professionals to target these issues. Triall has developed software solutions that are integrated with blockchain technology. These solutions make clinical trials tamper-resistant, and enable secure integrations between the many isolated systems and parties involved in clinical trials. Hence, they promise to shape the world’s first digital ecosystem for clinical trials.
Triall’s blockchain functionalities and ecosystem approach are unique in the 200-billion-dollar clinical trial industry. The project directly answers to growing calls for system interoperability and data traceability as voiced by regulators such as the FDA and EMA, and by a growing body of clinical trial professionals around the world. The project introduces a two-token system that functions as the ecosystem’s primary means of payment, while also facilitating community engagement, governance, and token lock-up incentives.
What is the highest value Triall (TRL) has ever reached?
Triall (TRL) reached its peak price at 0.9755 $ on 04 November 2021, approximately 4 years ago ago. Presently, the current price is -99.71% lower than this all-time high.
What is the historical minimum price for Triall (TRL)?
The minimum price reached for Triall (TRL) was 0.001667 $, documented on 08 September 2024, more than a year ago. In comparison, the current price is 66.91%, it above this historical low.
What is the fully diluted valuation of Triall (TRL)?
The fully diluted valuation (FDV) of Triall (TRL) stands at $ 478,950. This figure reflects the maximum potential market capitalization, considering that the current circulating supply is at its maximum of TRL tokens. The realization of this FDV might take several years depending on the emission schedule of TRL tokens.
How to add Triall (TRL) to MetaMask?
By integrating Triall (TRL) into MetaMask, you gain access to features like monitoring your token balances and trading on decentralized exchanges. To do this, you'll need to import TRL as a token. You can either manually import TRL by copying its contract address (0xe2eb47954e821dc94e19013677004cd59be0b17f) or use MetaMask's Chrome extension to add TRL with a single click through P.CASH.
How to add Triall (TRL) to TrustWallet?
Incorporating Triall (TRL) into your TrustWallet setup enables you to monitor your token holdings and engage in decentralized exchange transactions, among other functions. To include TRL, you can either manually import it using the contract address (0xe2eb47954e821dc94e19013677004cd59be0b17f) or conveniently add it to Trust Wallet with just one click via P.CASH if you've installed Trust Wallet's Chrome extension.
IMPORTANT DISCLAIMER:
The information presented on our website and associated platforms is sourced from third parties and is intended for general informational purposes only. We do not guarantee the accuracy or timeliness of this content. None of the information provided should be construed as financial, legal, or other professional advice tailored to your specific needs. Your use of this content is at your own discretion and risk. It's important to independently research, evaluate, and verify the information before relying on it. Trading carries significant risks, so it's advisable to consult with a financial advisor before making any decisions. Our content is not intended to solicit or offer any services.